Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B

Nature volume 479, pages 401–405 (2011)Cite this article

Subjects

Abstract

Members of the killer cell immunoglobulin-like receptor (KIR) family, a large group of polymorphic receptors expressed on natural killer (NK) cells, recognize particular peptide-laden human leukocyte antigen (pHLA) class I molecules and have a pivotal role in innate immune responses1. Allelic variation and extensive polymorphism within the three-domain KIR family (KIR3D, domains D0–D1–D2) affects pHLA binding specificity and is linked to the control of viral replication and the treatment outcome of certain haematological malignancies1,2,3. Here we describe the structure of a human KIR3DL1 receptor bound to HLA-B*5701 complexed with a self-peptide. KIR3DL1 clamped around the carboxy-terminal end of the HLA-B*5701 antigen-binding cleft, resulting in two discontinuous footprints on the pHLA. First, the D0 domain, a distinguishing feature of the KIR3D family, extended towards β2-microglobulin and abutted a region of the HLA molecule with limited polymorphism, thereby acting as an ‘innate HLA sensor’ domain. Second, whereas the D2–HLA-B*5701 interface exhibited a high degree of complementarity, the D1–pHLA-B*5701 contacts were suboptimal and accommodated a degree of sequence variation both within the peptide and the polymorphic region of the HLA molecule. Although the two-domain KIR (KIR2D) and KIR3DL1 docked similarly onto HLA-C4,5 and HLA-B respectively, the corresponding D1-mediated interactions differed markedly, thereby providing insight into the specificity of KIR3DL1 for discrete HLA-A and HLA-B allotypes. Collectively, in association with extensive mutagenesis studies at the KIR3DL1–pHLA-B*5701 interface, we provide a framework for understanding the intricate interplay between peptide variability, KIR3D and HLA polymorphism in determining the specificity requirements of this essential innate interaction that is conserved across primate species.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Structure of the KIR3DL1*001–pHLA-B*5701 complex.
Figure 2: Contacts between the KIR3DL1*001 receptor and pHLA-B*5701.
Figure 3: Mutational analysis at the KIR3DL1*001–pHLA-B*5701 interface.
Figure 4: Mapping of polymorphisms and sequence variations onto the structure of KIR3DL1*001.

Accession codes

Primary accessions

Protein Data Bank

Data deposits

The atomic coordinates and structure factors for the KIR3DL*001–pHLA-B*5701 complex were deposited in the Protein Data Bank under accession code 3VH8.

References

  1. Parham, P. MHC class I molecules and KIRs in human history, health and survival. Nature Rev. Immunol. 5, 201–214 (2005)

    Article  CAS  Google Scholar 

  2. Sanjanwala, B., Draghi, M., Norman, P. J., Guethlein, L. A. & Parham, P. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1. J. Immunol. 181, 6293–6300 (2008)

    Article  CAS  Google Scholar 

  3. Martin, M. P. et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nature Genet. 39, 733–740 (2007)

    Article  CAS  Google Scholar 

  4. Boyington, J. C., Motyka, S. A., Schuck, P., Brooks, A. G. & Sun, P. D. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405, 537–543 (2000)

    Article  ADS  CAS  Google Scholar 

  5. Fan, Q. R., Long, E. O. & Wiley, D. C. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1–HLA–Cw4 complex. Nature Immunol. 2, 452–460 (2001)

    Article  ADS  CAS  Google Scholar 

  6. Colonna, M. & Samaridis, J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268, 405–408 (1995)

    Article  ADS  CAS  Google Scholar 

  7. Chessman, D. et al. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 28, 822–832 (2008)

    Article  CAS  Google Scholar 

  8. Litwin, V., Gumperz, J., Parham, P., Phillips, J. H. & Lanier, L. L. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180, 537–543 (1994)

    Article  CAS  Google Scholar 

  9. Gumperz, J. E., Litwin, V., Phillips, J. H., Lanier, L. L. & Parham, P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181, 1133–1144 (1995)

    Article  CAS  Google Scholar 

  10. Cella, M., Longo, A., Ferrara, G. B., Strominger, J. L. & Colonna, M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J. Exp. Med. 180, 1235–1242 (1994)

    Article  CAS  Google Scholar 

  11. Petrie, E. J. et al. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J. Exp. Med. 205, 725–735 (2008)

    Article  CAS  Google Scholar 

  12. Hülsmeyer, M. et al. Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide. J. Mol. Biol. 346, 1367–1379 (2005)

    Article  Google Scholar 

  13. Peruzzi, M., Parker, K. C., Long, E. O. & Malnati, M. S. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J. Immunol. 157, 3350–3356 (1996)

    CAS  PubMed  Google Scholar 

  14. Fadda, L. et al. Peptide antagonism as a mechanism for NK cell activation. Proc. Natl Acad. Sci. USA 107, 10160–10165 (2010)

    Article  ADS  CAS  Google Scholar 

  15. Maenaka, K. et al. Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J. Biol. Chem. 274, 28329–28334 (1999)

    Article  CAS  Google Scholar 

  16. Trowsdale, J. et al. The genomic context of natural killer receptor extended gene families. Immunol. Rev. 181, 20–38 (2001)

    Article  CAS  Google Scholar 

  17. Norman, P. J. et al. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nature Genet. 39, 1092–1099 (2007)

    Article  CAS  Google Scholar 

  18. Martin, M. P. et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nature Genet. 31, 429–434 (2002)

    Article  CAS  Google Scholar 

  19. Carr, W. H. et al. Cutting edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J. Immunol. 178, 647–651 (2007)

    Article  CAS  Google Scholar 

  20. Sharma, D. et al. Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402. J. Immunol. 183, 4569–4582 (2009)

    Article  CAS  Google Scholar 

  21. O’Connor, G. M. et al. Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1. J. Immunol. 187, 2162–2171 (2011)

    Article  Google Scholar 

  22. Dohring, C., Scheidegger, D., Samaridis, J., Cella, M. & Colonna, M. A human killer inhibitory receptor specific for HLA-A1,2. J. Immunol. 156, 3098–3101 (1996)

    CAS  PubMed  Google Scholar 

  23. Hansasuta, P. et al. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur. J. Immunol. 34, 1673–1679 (2004)

    Article  CAS  Google Scholar 

  24. Yawata, M. et al. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 203, 633–645 (2006)

    Article  CAS  Google Scholar 

  25. Khakoo, S. I., Geller, R., Shin, S., Jenkins, J. A. & Parham, P. The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer. J. Exp. Med. 196, 911–921 (2002)

    Article  CAS  Google Scholar 

  26. Carr, W. H., Pando, M. J. & Parham, P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 175, 5222–5229 (2005)

    Article  CAS  Google Scholar 

  27. Godfrey, D. I., Rossjohn, J. & McCluskey, J. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Immunity 28, 304–314 (2008)

    Article  CAS  Google Scholar 

  28. Aricescu, A. R., Lu, W. & Jones, E. Y. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr. D 62, 1243–1250 (2006)

    Article  Google Scholar 

  29. Davis, I. W. et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, W375–W383 (2007)

    Article  ADS  Google Scholar 

Download references

Acknowledgements

We thank the staff at the MX2 beamline of the Australian synchrotron for assistance with data collection. We thank A. Radu Aricescu for the gift of the pHLsec vector. This research was supported by the National Health and Medical Research Council of Australia (NHMRC), the Australian Research Council (ARC) and the Intramural Research Programs of the National Cancer Institute and the National Institute of Allergy and Infectious Diseases, National Institutes of Health. D.W.M. and G.M.O'C. were supported by the Intramural AIDS Targeted Antiviral Program of the National Institutes of Health. J.P.V. is supported by an NHMRC Peter Doherty Research Fellowship; D.A.P. is supported by a Medical Research Council (UK) Senior Clinical Fellowship; B.A.P.L. is supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; C.S.C. is supported by an ARC QEII Fellowship; J.R. is supported by an ARC Federation Fellowship.

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria 3800, Australia

    Julian P. Vivian, Renee C. Duncan, Richard Berry, Hugh H. Reid, Travis Beddoe, Stephanie Gras, Maya A. Olshina, Craig S. Clements & Jamie Rossjohn

  2. Cancer and Inflammation Program, National Cancer Institute-Frederick, Frederick, 21702, Maryland, USA

    Geraldine M. O’Connor & Daniel W. McVicar

  3. Department of Microbiology & Immunology, University of Melbourne, Parkville, Victoria 3010, Australia

    Philippa M. Saunders, Jacqueline M. L. Widjaja, Christopher M. Harpur, Jie Lin & Andrew G. Brooks

  4. Non-Human Primate Immunogenetics and Cellular Immunology Unit, Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 20892, Maryland, USA

    Sebastien M. Maloveste & Bernard A. P. Lafont

  5. Department of Infection, Immunity and Biochemistry, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, Wales, UK

    David A. Price & Jamie Rossjohn

  6. Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 20892, Maryland, USA

    David A. Price

Authors
  1. Julian P. Vivian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Renee C. Duncan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard Berry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Geraldine M. O’Connor
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hugh H. Reid
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Travis Beddoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stephanie Gras
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Philippa M. Saunders
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Maya A. Olshina
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jacqueline M. L. Widjaja
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Christopher M. Harpur
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jie Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Sebastien M. Maloveste
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. David A. Price
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Bernard A. P. Lafont
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Daniel W. McVicar
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Craig S. Clements
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Andrew G. Brooks
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Jamie Rossjohn
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J.P.V. solved the structure, undertook analysis, performed experiments and contributed to manuscript preparation. H.H.R., T.B., R.C.D., R.B., P.M.S., M.A.O., J.M.L.W., C.M.H., J.L., S.M.M., S.G. and C.S.C. performed experiments and/or analysed data. G.M.O’C., D.A.P., B.A.P.L. and D.W.M. performed experiments and/or analysed data and contributed to the writing of the manuscript; A.G.B. and J.R. were the joint senior authors—they co-led the investigation, devised the project, analysed the data and wrote the manuscript.

Supplementary information

Supplementary Information

The file contains Supplementary Figures 1-7 with legends and Supplementary Tables 1-3. (PDF 15308 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Vivian, J., Duncan, R., Berry, R. et al. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 479, 401–405 (2011). https://doi.org/10.1038/nature10517

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature10517

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing